FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3120149102> ?p ?o ?g. }

• W3120149102 abstract "Abstract Purpose We aimed to describe the demographics, cancer subtypes, comorbidities and outcomes of patients with a history of cancer with COVID-19 from March to June 2020. Secondly, we compared patients hospitalized with COVID-19 to patients diagnosed with COVID-19 and patients hospitalized with influenza. Methods We conducted a cohort study using eight routinely-collected healthcare databases from Spain and the US, standardized to the Observational Medical Outcome Partnership common data model. Three cohorts of patients with a history of cancer were included: i) diagnosed with COVID-19, ii) hospitalized with COVID-19, and iii) hospitalized with influenza in 2017-2018. Patients were followed from index date to 30 days or death. We reported demographics, cancer subtypes, comorbidities, and 30-day outcomes. Results We included 118,155 patients with a cancer history in the COVID-19 diagnosed and 41,939 in the COVID-19 hospitalized cohorts. The most frequent cancer subtypes were prostate and breast cancer (range: 5-19% and 1-14% in the diagnosed cohort, respectively). Hematological malignancies were also frequent, with non-Hodgkin’s lymphoma being among the 5 most common cancer subtypes in the diagnosed cohort. Overall, patients were more frequently aged above 65 years and had multiple comorbidities. Occurrence of death ranged from 8% to 14% and from 18% to 26% in the diagnosed and h ospitalized COVID-19 cohorts, respectively. Patients hospitalized with influenza (n=242,960) had a similar distribution of cancer subtypes, sex, age and comorbidities but lower occurrence of adverse events. Conclusion Patients with a history of cancer and COVID-19 have advanced age, multiple comorbidities, and a high occurence of COVID-19-related events. Additionaly, hematological malignancies were frequent in these patients.This observational study provides epidemiologic characteristics that can inform clinical care and future etiological studies." @default.
• W3120149102 created "2021-01-18" @default.
• W3120149102 creator A5007026238 @default.
• W3120149102 creator A5007968730 @default.
• W3120149102 creator A5011676848 @default.
• W3120149102 creator A5014773041 @default.
• W3120149102 creator A5015201397 @default.
• W3120149102 creator A5017487533 @default.
• W3120149102 creator A5018241648 @default.
• W3120149102 creator A5018656230 @default.
• W3120149102 creator A5020199821 @default.
• W3120149102 creator A5021541475 @default.
• W3120149102 creator A5022258704 @default.
• W3120149102 creator A5023396800 @default.
• W3120149102 creator A5026965117 @default.
• W3120149102 creator A5027189955 @default.
• W3120149102 creator A5028947868 @default.
• W3120149102 creator A5029938560 @default.
• W3120149102 creator A5034290023 @default.
• W3120149102 creator A5035447051 @default.
• W3120149102 creator A5037435182 @default.
• W3120149102 creator A5038076932 @default.
• W3120149102 creator A5038513749 @default.
• W3120149102 creator A5038700066 @default.
• W3120149102 creator A5039905606 @default.
• W3120149102 creator A5041175834 @default.
• W3120149102 creator A5041240121 @default.
• W3120149102 creator A5041333542 @default.
• W3120149102 creator A5042973046 @default.
• W3120149102 creator A5043592562 @default.
• W3120149102 creator A5043757098 @default.
• W3120149102 creator A5047368997 @default.
• W3120149102 creator A5048565316 @default.
• W3120149102 creator A5049095304 @default.
• W3120149102 creator A5049836374 @default.
• W3120149102 creator A5051987065 @default.
• W3120149102 creator A5054270096 @default.
• W3120149102 creator A5056102838 @default.
• W3120149102 creator A5057880586 @default.
• W3120149102 creator A5062899845 @default.
• W3120149102 creator A5065153070 @default.
• W3120149102 creator A5065237145 @default.
• W3120149102 creator A5067037082 @default.
• W3120149102 creator A5067070509 @default.
• W3120149102 creator A5067620656 @default.
• W3120149102 creator A5068067952 @default.
• W3120149102 creator A5070904378 @default.
• W3120149102 creator A5071806566 @default.
• W3120149102 creator A5072147450 @default.
• W3120149102 creator A5074601848 @default.
• W3120149102 creator A5080504163 @default.
• W3120149102 creator A5080516734 @default.
• W3120149102 creator A5082180580 @default.
• W3120149102 creator A5087836082 @default.
• W3120149102 creator A5088853712 @default.
• W3120149102 date "2021-01-15" @default.
• W3120149102 modified "2023-09-27" @default.
• W3120149102 title "Characteristics and outcomes of 118,155 COVID-19 individuals with a history of cancer in the United States and Spain" @default.
• W3120149102 cites W2036193982 @default.
• W3120149102 cites W2157365260 @default.
• W3120149102 cites W2585056247 @default.
• W3120149102 cites W2951071083 @default.
• W3120149102 cites W3006355661 @default.
• W3120149102 cites W3008827533 @default.
• W3120149102 cites W3012696018 @default.
• W3120149102 cites W3012860910 @default.
• W3120149102 cites W3016535995 @default.
• W3120149102 cites W3026764413 @default.
• W3120149102 cites W3028583791 @default.
• W3120149102 cites W3028965239 @default.
• W3120149102 cites W3030347371 @default.
• W3120149102 cites W3046316152 @default.
• W3120149102 cites W3080162924 @default.
• W3120149102 cites W3082480386 @default.
• W3120149102 cites W3087982800 @default.
• W3120149102 cites W3088407675 @default.
• W3120149102 cites W3092444344 @default.
• W3120149102 cites W3092952083 @default.
• W3120149102 cites W3093192541 @default.
• W3120149102 cites W3214249844 @default.
• W3120149102 doi "https://doi.org/10.1101/2021.01.12.21249672" @default.
• W3120149102 hasPublicationYear "2021" @default.
• W3120149102 type Work @default.
• W3120149102 sameAs 3120149102 @default.
• W3120149102 citedByCount "0" @default.
• W3120149102 crossrefType "posted-content" @default.
• W3120149102 hasAuthorship W3120149102A5007026238 @default.
• W3120149102 hasAuthorship W3120149102A5007968730 @default.
• W3120149102 hasAuthorship W3120149102A5011676848 @default.
• W3120149102 hasAuthorship W3120149102A5014773041 @default.
• W3120149102 hasAuthorship W3120149102A5015201397 @default.
• W3120149102 hasAuthorship W3120149102A5017487533 @default.
• W3120149102 hasAuthorship W3120149102A5018241648 @default.
• W3120149102 hasAuthorship W3120149102A5018656230 @default.
• W3120149102 hasAuthorship W3120149102A5020199821 @default.
• W3120149102 hasAuthorship W3120149102A5021541475 @default.
• W3120149102 hasAuthorship W3120149102A5022258704 @default.
• W3120149102 hasAuthorship W3120149102A5023396800 @default.
• W3120149102 hasAuthorship W3120149102A5026965117 @default.
• W3120149102 hasAuthorship W3120149102A5027189955 @default.

• next